Showing 25 to 36 of 115 results
HHS Officials Pressured CDC Head to Accept Vaccine Restrictions Before Ouster
In the weeks before Dr. Susan Monarez's dismissal as CDC head, top HHS officials, including acting CDC director Jim O'Neill, repeatedly urged her to endorse potential vaccine restrictions, leading to a standoff that culminated in her firing and a crisis at the agency.
HHS Officials Pressured CDC Head to Accept Vaccine Restrictions Before Ouster
In the weeks before Dr. Susan Monarez's dismissal as CDC head, top HHS officials, including acting CDC director Jim O'Neill, repeatedly urged her to endorse potential vaccine restrictions, leading to a standoff that culminated in her firing and a crisis at the agency.
Progress
28% Bias Score
Kennedy's Decision to Halt mRNA Research Funding Threatens Future Medical Advancements
President Trump's Operation Warp Speed initiative rapidly developed mRNA COVID-19 vaccines, saving millions of lives; however, Secretary Kennedy's decision to end federal mRNA research funding threatens future medical advancements and pandemic preparedness.
Kennedy's Decision to Halt mRNA Research Funding Threatens Future Medical Advancements
President Trump's Operation Warp Speed initiative rapidly developed mRNA COVID-19 vaccines, saving millions of lives; however, Secretary Kennedy's decision to end federal mRNA research funding threatens future medical advancements and pandemic preparedness.
Progress
60% Bias Score
Liver Cancer Cases Projected to Nearly Double by 2050
A new global study projects a near doubling of liver cancer cases by 2050, reaching over 1.5 million, driven by preventable risk factors such as Hepatitis B and C, alcohol use, and obesity, highlighting a critical global health crisis.
Liver Cancer Cases Projected to Nearly Double by 2050
A new global study projects a near doubling of liver cancer cases by 2050, reaching over 1.5 million, driven by preventable risk factors such as Hepatitis B and C, alcohol use, and obesity, highlighting a critical global health crisis.
Progress
32% Bias Score
1.4 Million Annual Hepatitis A Infections Highlight Global Sanitation Disparities
The World Health Organization reports 1.4 million annual Hepatitis A infections globally, primarily in developing nations due to poor sanitation; transmission occurs through contaminated water and food, but a vaccine exists.
1.4 Million Annual Hepatitis A Infections Highlight Global Sanitation Disparities
The World Health Organization reports 1.4 million annual Hepatitis A infections globally, primarily in developing nations due to poor sanitation; transmission occurs through contaminated water and food, but a vaccine exists.
Progress
40% Bias Score
US Removes Thimerosal from All Flu Vaccines
The US Department of Health and Human Services adopted a recommendation to remove the mercury-based preservative thimerosal from all US influenza vaccines, following a 5-1 vote by a newly appointed CDC advisory committee, despite limited evidence of harm and concerns about reduced vaccine access.
US Removes Thimerosal from All Flu Vaccines
The US Department of Health and Human Services adopted a recommendation to remove the mercury-based preservative thimerosal from all US influenza vaccines, following a 5-1 vote by a newly appointed CDC advisory committee, despite limited evidence of harm and concerns about reduced vaccine access.
Progress
52% Bias Score
Sanofi to Acquire Vicebio for $1.6 Billion, Expanding Vaccine Portfolio
French pharmaceutical giant Sanofi is acquiring British biotech firm Vicebio for up to $1.6 billion, gaining access to its novel combination vaccine candidate for RSV and hMPV, and its 'Molecular Clamp' technology, with the deal expected to close in the fourth quarter of 2025.
Sanofi to Acquire Vicebio for $1.6 Billion, Expanding Vaccine Portfolio
French pharmaceutical giant Sanofi is acquiring British biotech firm Vicebio for up to $1.6 billion, gaining access to its novel combination vaccine candidate for RSV and hMPV, and its 'Molecular Clamp' technology, with the deal expected to close in the fourth quarter of 2025.
Progress
32% Bias Score
COVID-19 Cases Rise in U.S. as School Starts, but Remain Below Previous Years' Levels
COVID-19 hospitalizations and positive test rates have doubled in the U.S. compared to two months prior, yet remain significantly lower than last year, with roughly 200 weekly deaths reported over the past two months.
COVID-19 Cases Rise in U.S. as School Starts, but Remain Below Previous Years' Levels
COVID-19 hospitalizations and positive test rates have doubled in the U.S. compared to two months prior, yet remain significantly lower than last year, with roughly 200 weekly deaths reported over the past two months.
Progress
24% Bias Score
Burkina Faso's National Malaria Vaccination Campaign and the Rise of Genetically Modified Mosquitoes
Burkina Faso launched a nationwide malaria vaccination campaign using the R21 vaccine, while over 18 countries have already adopted malaria vaccines to protect children. The spread of insecticide-resistant Anopheles stephensi mosquitoes necessitates innovative solutions like genetically modified mos...
Burkina Faso's National Malaria Vaccination Campaign and the Rise of Genetically Modified Mosquitoes
Burkina Faso launched a nationwide malaria vaccination campaign using the R21 vaccine, while over 18 countries have already adopted malaria vaccines to protect children. The spread of insecticide-resistant Anopheles stephensi mosquitoes necessitates innovative solutions like genetically modified mos...
Progress
48% Bias Score
Virtual Illness Triggers Immune Response: VR Study
A Swiss study found that exposure to virtual reality scenarios depicting sick individuals triggered an immune response in participants, as measured by brain activity and increased innate lymphoid cell activity in blood samples, suggesting the body may preemptively prepare for potential threats.
Virtual Illness Triggers Immune Response: VR Study
A Swiss study found that exposure to virtual reality scenarios depicting sick individuals triggered an immune response in participants, as measured by brain activity and increased innate lymphoid cell activity in blood samples, suggesting the body may preemptively prepare for potential threats.
Progress
16% Bias Score
Hepatitis: Differences, Prevention, and Global Impact
The 2020 Nobel Prize in Physiology or Medicine recognized the discovery of Hepatitis C virus, a blood-borne disease causing liver inflammation and potentially cirrhosis or liver cancer; vaccines exist for Hepatitis A and B, but not C.
Hepatitis: Differences, Prevention, and Global Impact
The 2020 Nobel Prize in Physiology or Medicine recognized the discovery of Hepatitis C virus, a blood-borne disease causing liver inflammation and potentially cirrhosis or liver cancer; vaccines exist for Hepatitis A and B, but not C.
Progress
16% Bias Score
Covid-19 Cases Rise in 27 States; Updated Vaccines Coming in Fall
As of July 15th, Covid-19 cases are rising in 27 US states, driven by the NB.1.8.1 variant (43% of cases) and LP.8.1 (31% of cases), though hospitalizations remain low; updated vaccines are expected in the fall, targeting high-risk groups.
Covid-19 Cases Rise in 27 States; Updated Vaccines Coming in Fall
As of July 15th, Covid-19 cases are rising in 27 US states, driven by the NB.1.8.1 variant (43% of cases) and LP.8.1 (31% of cases), though hospitalizations remain low; updated vaccines are expected in the fall, targeting high-risk groups.
Progress
44% Bias Score
FDA Rejects COVID-19 Vaccines Amidst Internal Upheaval
The FDA, under the direction of its new chief scientist Vinay Prasad and Health Secretary Robert Kennedy, rejected the approval of Moderna and Novavax's COVID-19 vaccines for those over 12, citing unsubstantiated risks despite clinical trial data; approximately 3,000 FDA employees have left or been ...
FDA Rejects COVID-19 Vaccines Amidst Internal Upheaval
The FDA, under the direction of its new chief scientist Vinay Prasad and Health Secretary Robert Kennedy, rejected the approval of Moderna and Novavax's COVID-19 vaccines for those over 12, citing unsubstantiated risks despite clinical trial data; approximately 3,000 FDA employees have left or been ...
Progress
56% Bias Score
Showing 25 to 36 of 115 results